A. Kawakami

Association of endogenous insulin secretion and mode of therapy with body fat and serum leptin levels in diabetic subjects.

T. Nakamura, T. Saito, S. Ishikawa, 1998, Metabolism: clinical and experimental.

Immunologically-related or incidental coexistence of diabetes mellitus and Graves' disease; discrimination by anti-GAD antibody measurement.

T. Nakamura, T. Saito, S. Nagasaka, 1999, Endocrine journal.

Association of CTLA‐4 polymorphism with positive anti‐GAD antibody in Japanese subjects with type 1 diabetes mellitus

S. Ishikawa, Takako Saito, S. Nagasaka, 1999, Clinical endocrinology.

Pioglitazone‐induced hepatic injury in a patient previously receiving troglitazone with success

S. Ishibashi, T. Nakamura, T. Saito, 2002, Diabetic medicine : a journal of the British Diabetic Association.

Serum levels of leptin and changes during the course of recovery from diabetic ketoacidosis.

T. Nakamura, T. Saito, S. Ishikawa, 1999, Diabetes research and clinical practice.

Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Urinary Excretion of Aquaporin-2 in the Diagnosis of Central Diabetes Insipidus*

F. Marumo, S. Sasaki, T. Nakamura, 2022 .

Contribution of a missense mutation (Trp64Arg) in beta3-adrenergic receptor gene to multiple risk factors in Japanese men with hyperuricemia.

T. Nakamura, T. Saito, S. Nagasaka, 1998, Endocrine journal.

SAT0486 TNF Inhibitors Have No Effects To Human T-Lymphotropic Virus Type-I (HTLV-I)-Infected Cell Line

H. Hasegawa, H. Nakamura, S. Fukui, 2016 .

Troglitazone efficacy in a subject with glucocorticoid-induced diabetes.

T. Nakamura, T. Saito, S. Nagasaka, 1999, Diabetes Care.